Menu Search
Equities

Magnera Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MAGN:BRN

Magnera Corp

Actions
  • Price (CHF)36.54
  • Today's Change0.00 / 0.00%
  • Shares traded553.38
  • 1 Year change--
  • Beta1.7020
Data delayed at least 15 minutes, as of Oct 28 2022.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Magnera Corporation is engaged in the specialty materials and nonwovens industry. The Company’s operations are organized into two operating segments: Americas and Rest of the World. The Americas segment consists of sites in North America and South America that manufacture a range of products and components of personal care and consumer solution products and components of products including medical garments, wipes, dryer sheets, face masks, filtration, baby diapers and adult incontinence. The Rest of World segment consists of sites throughout Europe and China that manufacture a broad collection of personal care and consumer solution products and components of products including medical garments, wipes, face masks, cable wrap, filtration, baby diapers and adult incontinence. Its solutions include nonwovens, and films and laminates. Its nonwovens include Spunmelt, Airlaid, Spunlace, Through Air Bonded, and Needlepunch. Its films and laminates include Typar, Chicopee, Sontara and Tubex.

  • Revenue in USD (TTM)3.20bn
  • Net income in USD-159.00m
  • Incorporated1905
  • Employees2.87k
  • Location
    Magnera Corp9335 Harris Corners Pkwy, Suite 300CHARLOTTE 28269United StatesUSA
  • Phone+1 (717) 225-2709
  • Websitehttps://magnera.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.